Dizal (jiangsu) Pharmaceutical Co., Ltd.

This study is testing a new combination of two drugs, DZD6008 and sunvozertinib, for people with advanced non-small cell lung cancer that has a specific genetic change (EGFR mutation). The main goals are to check the safety of this combination, see how the drugs move through the …

This study is testing whether a daily pill called sunvozertinib can help prevent lung cancer from returning in people who have had surgery to remove their tumor. It will compare the pill to a placebo in 360 adults with a specific type of non-small cell lung cancer and certain gen…

This study is testing whether adding the experimental drug DZD8586 to treatment helps control chronic lymphocytic leukemia or small lymphocytic lymphoma. Researchers will enroll 66 adults with newly diagnosed or untreated forms of these blood cancers. The trial has two parts: fir…

This study is testing whether an experimental drug called DZD8586 works better than standard treatments at controlling cancer growth in adults with chronic lymphocytic leukemia or small lymphocytic lymphoma that has returned or stopped responding to prior therapy. About 250 parti…